In this study we compared the effects of propofol, small-dose isoflurane, and nitrous oxide (N 2 O) on cortical somatosensory evoked potentials (SSEP) and bispectral index (BIS) monitoring in adolescents undergoing spinal fusion. Twelve patients received the following anesthetic maintenance combinations in a randomly determined order: treatment #1: isoflurane 0.4% ϩ N 2 O 70% ϩ O 2 30%; treatment #2: isoflurane 0.6% ϩ N 2 O 70% ϩ O 2 30%; treatment #3: isoflurane 0.6% ϩ air ϩ O 2 30%; treatment #4: propofol 120 g · kg Ϫ1 · min Ϫ1 ϩ air ϩ O 2 30%. Cortical SSEP amplitudes measured during anesthesia maintenance with treatment #3 (isoflurane 0.6%/air) were more than those measured during maintenance with treatment #1 (isoflurane 0.4%/N 2 O 70%) (P Ͻ 0.0001) and treatment #2 (isoflurane 0.6%/N 2 O 70%) (P Ͻ 0.0052). Cortical SSEP amplitudes measured during treatment #4 (propofol 120 g · kg Ϫ1 · min Ϫ1 /air) were more than treatment #1 (isoflurane 0.4%/N 2 O 70%) (P Ͻ 0.0001), treatment #2 (Iso 0.6%/N 2 O 70%) (P Ͻ 0.0007), and treatment #3 (isoflurane 0.6%/air) (P Ͻ 0.0191). In addition, average BIS values measured during treatments 1, 2, 3 and 4 were 62, 62, 61, and 44 respectively. Only treatment #4 (propofol 120 g · kg Ϫ1 · min Ϫ1 /air) uniformly maintained BIS values less than 60. Our study demonstrates that propofol better preserves cortical SSEP amplitude measurement and provides a deeper level of hypnosis as measured by BIS values than combinations of small-dose isoflurane/N 2 O or small-dose isoflurane alone.
In this study we compared the effects of propofol, small-dose isoflurane, and nitrous oxide (N 2 O) on cortical somatosensory evoked potentials (SSEP) and bispectral index (BIS) monitoring in adolescents undergoing spinal fusion. Twelve patients received the following anesthetic maintenance combinations in a randomly determined order: treatment #1: isoflurane 0.4% ϩ N 2 O 70% ϩ O 2 30%; treatment #2: isoflurane 0.6% ϩ N 2 O 70% ϩ O 2 30%; treatment #3: isoflurane 0.6% ϩ air ϩ O 2 30%; treatment #4: propofol 120 g · kg Ϫ1 · min Ϫ1 ϩ air ϩ O 2 30%. Cortical SSEP amplitudes measured during anesthesia maintenance with treatment #3 (isoflurane 0.6%/air) were more than those measured during maintenance with treatment #1 (isoflurane 0.4%/N 2 O 70%) (P Ͻ 0.0001) and treatment #2 (isoflurane 0.6%/N 2 O 70%) (P Ͻ 0.0052). Cortical SSEP amplitudes measured during treatment #4 (propofol 120 g · kg Ϫ1 · min Ϫ1 /air) were more than treatment #1 (isoflurane 0.4%/N 2 O 70%) (P Ͻ 0.0001), treatment #2 (Iso 0.6%/N 2 O 70%) (P Ͻ 0.0007), and treatment #3 (isoflurane 0.6%/air) (P Ͻ 0.0191). In addition, average BIS values measured during treatments 1, 2, 3 and 4 were 62, 62, 61, and 44 respectively. Only treatment #4 (propofol 120 g · kg Ϫ1 · min Ϫ1 /air) uniformly maintained BIS values less than 60. Our study demonstrates that propofol better preserves cortical SSEP amplitude measurement and provides a deeper level of hypnosis as measured by BIS values than combinations of small-dose isoflurane/N 2 O or small-dose isoflurane alone. T he effect of anesthetics on cortical somatosensory evoked potential (SSEP) monitoring has been a subject of intense research over the last two decades (1) . Volatile anesthetics have been repeatedly shown to decrease cortical amplitude in a dosedependent fashion (2) (3) (4) (5) . Nitrous oxide (N 2 O) reduces cortical amplitude more than volatile anesthetics, and their combined effect is even more dramatic (3) (4) (5) (6) (7) (8) . Opioids, barbiturates, and propofol have a much less profound effect (9 -16) . In fact, propofol has been shown to preserve cortical waveform amplitude and latency even with escalating doses (16) .
Despite clear evidence that N 2 O and isoflurane adversely affect cortical SSEP amplitude generation, many anesthesiologists use combinations of these two drugs at variable doses. Perhaps this is because cortical SSEP measurement is possible in the setting of 50%-70% N 2 O and 0.5 minimal alveolar concentration (MAC) isoflurane for most neurologically intact adults (3) (4) (5) (6) . However, this anesthetic combination may be unacceptable for small children and patients with abnormal baseline SSEPs from neurological deficits (17) (18) . Furthermore, these subanesthetic doses may place the patient at risk for intraoperative recall.
The purpose of this study was to compare the effects of four different but commonly used anesthetic combinations on cortical SSEP monitoring and to test the hypothesis that a propofol-based total IV anesthetic (TIVA) technique would induce less change in cortical SSEP amplitude and produce a deeper level of hypnosis as measured by bispectral index (BIS) than combinations of small-dose isoflurane/N 2 O or small-dose isoflurane/air.
Methods
Twelve healthy adolescents undergoing spinal fusion for idiopathic scoliosis repair were selected for this study (Table 1) .
After IRB approval, parental consent, and patient assent, patients underwent anterior-posterior spinal fusion (1) or posterior spinal fusion (11) . The following routine monitors were applied: electrocardiogram, noninvasive blood pressure cuff, radial arterial line, pulse oximetry, end-tidal CO 2 , esophageal temperature probe, nerve stimulator, and urinary catheter. In addition, the Nicolet (Madison, WI) Viking 4 and XLTEK EP 16 monitors were used to measure SSEP data and the BIS (Aspect, XP A2000; Aspect Medical Systems, Newton, MA) monitor was used to measure relative depths of hypnosis.
All patients were premedicated with midazolam (0.5 mg/kg, maximum 20 mg PO) 20 min before arrival in the operating room. Patients underwent either inhaled induction with sevoflurane, N 2 O, and oxygen, or IV induction with propofol (2-3 mg/kg). Tracheal intubation occurred after muscle relaxation with cisatracurium (0.2 mg/kg).
After induction, each patient received 4 different anesthetic maintenance combinations in a randomly determined order. Each maintenance combination was administered for 20 min before monitoring values and SSEP data were collected. The anesthetic combinations were as follows:
Remifentanil infusion was added to all of the above anesthetic combinations and titrated to maintain the baseline mean arterial blood pressures throughout the study period. A cisatracurium infusion was used to maintain train-of-four neuromuscular blockade at 0 -2/4.
Before switching from one of the isoflurane-based maintenance combinations (treatments 1, 2, 3) to the propofol-based maintenance combination (treatment 4), patients received a propofol bolus (2 mg/kg) to help saturate nonspecific binding sites and promote rapid steady-state serum propofol levels. Serum propofol levels were measured in all patients during maintenance with propofol (treatment 4) and, depending on the sequence of anesthetic combinations that were randomly assigned, again for those patients switching from the propofol treatment to one of the isoflurane combinations (treatments 1, 2, 3) after 20 min of equilibration. Serum propofol levels were analyzed using high-performance liquid chromatography with fluorescence detection.
BIS measurements were recorded for each anesthetic combination after 20 min of equilibration. These values were purely descriptive, and no attempt was made to adjust medications for the sake of achieving a target BIS value.
SSEPs were recorded throughout surgery, except when electrocautery precluded recording. Stimulating electrodes were placed over both posterior tibial nerves at the ankles. Right and left posterior tibial SSEPs were obtained independently. Typically, 500 individual responses were averaged for each evoked potential measurement. Stimulation intensity was 15-20 Ma, and the stimulation rate was 4.3/sec. Recordings were obtained from electrodes placed at scalp locations CP3, CPz, CP4, and Fpz, according to the modified 10 -20 system, and on the chin (19) . The cortical P38 component of the SSEP was detected using CPz-Fpz and CP3-CP4 derivations for left posterior tibial SSEPs and CPz-Fpz and CP4-CP3 derivations for right posterior tibial SSEPs. Subcortical P31 and N34 components were detected using an Fpz-chin electrode derivation. All recordings were replicated and superimposed to demonstrate reproducibility. The passband was 30 to 1000 Hz (Ϫ6 db).
The amplitude of the cortical P38 component was measured as the greater of the P38 voltages CPz-Fpz and CP3-CP4 (or CP4-CP3) derivations. In each of these derivations, the P38 voltage was measured from the P38 peak positivity to the peak of the subsequent negative wave. The amplitude of the N34 negativity was measured with respect to the preceding P31 peak. Latencies measurements were made for the P38 and N34 peaks as illustrated in Figure 1b .
All anesthetic changes and measurements were achieved during the initial stages of surgery. Surgical manipulation of the spinal cord and traction of the spine did not take place at any time during the study period.
Morphine or hydromorphone was administered to each patient during the closing stages of surgery, and titrated to patient comfort upon extubation. A morphine or hydromorphone patient controlled analgesia device was given to each patient in the recovery room for further pain management.
Repeated measurements of analysis of variance (SAS PROC MIXED; SAS, Cary, NC) were conducted to investigate any differences in SSEP (cortical amplitude, cortical latency, subcortical amplitude, subcortical latency) or BIS measurements arising among anesthetic maintenance treatment groups. Differences detected by analysis of variance were further examined by the Tukey-Kramer method, and the P values were adjusted accordingly to maintain an experimental-wide error rate of 0.05. Pearson correlation tests were conducted to detect correlations between heart rate, mean arterial blood pressure, temperature, and remifentanil dose with SSEP or BIS measurements.
Results
Cortical SSEP amplitudes measured during anesthesia maintenance with treatment #3 (isoflurane 0.6%/air) were greater than those measured during maintenance with treatment #1 (isoflurane 0.4%/N 2 O 70%) (P Ͻ 0.0001) and treatment #2 (isoflurane 0.6%/N 2 O 70%) (P Ͻ 0.0052). Cortical SSEP amplitudes measured during Treatment #4 (propofol 120 g · kg Ϫ1 · min Ϫ1 / air) were greater than treatment #1 (isoflurane 0.4%/ N 2 O 70%) (P Ͻ 0.0001), treatment #2 (isoflurane 0.6%/ N 2 O 70%) (P Ͻ 0.0007), and treatment #3 (isoflurane 0.6%/air) (P Ͻ 0.0191) (Figures 1 and 2) .
In one patient, cortical amplitude measurement was not possible during maintenance with treatment #2 (isoflurane 0.6%/N 2 O 70%). No statistical difference could be found between treatment groups #1 and #2. Among the four treatment groups, no significant differences in cortical latencies, subcortical amplitudes, or subcortical latencies were found.
Average BIS values measured during treatments 1, 2, 3, and 4 were 62, 62, 61, and 44 respectively. Only treatment #4 (propofol 120 g · kg Ϫ1 · min Ϫ1 / air) uniformly maintained BIS values less than 60 ( Figure 3) .
No significant correlations were found between heart rate, mean arterial blood pressure, temperature, or remifentanil dose with either SSEP or BIS measurements using the Pearson correlation test. Average remifentanil doses (g · kg Ϫ1 · min Ϫ1 ) were 0.31, 0.23, 0.35, and 0.40 for treatments 1, 2, 3, and 4, respectively.
The average serum propofol level for all patients during maintenance with treatment #4 (propofol 120 g · kg Ϫ1 · min Ϫ1 /air) was 2.04 g/mL. Those patients randomized to switch from treatment #4 to one of the isoflurane combinations demonstrated an average subsequent serum level of 0.35 g/mL. Discussion SSEP recording uses signal averaging to extract very low voltage physiological signals from a background of higher voltage noise. The efficiency of the recording process is critically dependent on maximizing the signalto-noise ratio (SNR) of the raw data before averaging. If the SNR of the raw data is too low, satisfactory SSEP monitoring is not possible. The SNR can be maximized by reducing the accompanying noise (e.g., the use of paralytic medications to eliminate electromyographic artifact) and by selecting recording derivations, stimulus variables, and anesthetics that maximize the voltage of the physiologic signals of interest. Creating the ideal anesthetic environment for cortical SSEP amplitude measurement remains a great challenge for anesthesiologists. Healthy adults with enormous baseline cortical amplitudes can be subjected to a variety of anesthetic conditions and still demonstrate adequately sized wave forms for continuing analysis (3-6). In contrast, general anesthesia often obliterates cortical SSEP responses in patients with very small baseline signals, such as healthy infants and young children, and patients with preexisting neurological disease (17, 18) . Indeed these patients are often monitored exclusively with subcortical SSEPs, which are less affected by anesthetics. Unfortunately, subcortical signals are not always obtainable or desirable.
This study objectively compared the impact of several common anesthetics on SSEP and BIS monitoring in healthy adolescents undergoing spinal fusion. We chose the class and dose of anesthetics based on community practice and work done by other researchers. The combinations of isoflurane 0.4%-0.6%/N 2 O 70%, and isoflurane 0.6%/air were examined in light of numerous adult studies documenting adequate SSEP measurement in the setting of isoflurane 0.5 MAC with N 2 O and 1 MAC without N 2 O, as well as the amnestic efficacy of 0.4 MAC (0.5%) isoflurane (3-6,20 -23) . Our choice of propofol 120 g · kg Ϫ1 · min Ϫ1 /air was based upon adult reports of adequate SSEP measurement and reliable amnesia with propofol doses of 100 g · kg Ϫ1 · min Ϫ1 (12) (13) (14) (15) (16) 24, 25) .
Because each patient has SSEP and BIS measurements that respond to anesthetics in an individual fashion, comparing groups of patients exposed to different medications may not be entirely valid. The strength of our study lies in its crossover design. Patients in our study served as their own controls, which allowed for direct, clinically relevant SSEP and BIS comparisons.
This crossover design, however, can be flawed if there is incomplete drug elimination between anesthetic treatment group changes. We based our 20-minute intervals for anesthetic equilibration upon the known pharmacokinetics of isoflurane, N 2 O, and propofol. Given the rapidity of equilibration/elimination for the inhaled anesthetics, we recognized that propofol pharmacokinetics would be the rate-limiting factor for our study. Thus, we wanted to validate the known pharmacokinetic models by objectively measuring serum propofol levels on every patient after 20 minutes of equilibration (2 mg/kg bolus followed by infusion at 120 g · kg Ϫ1 · min Ϫ1 ) and again for those patients whose anesthetic sequence required switching from the propofol treatment to one of the isoflurane combinations. Our results revealed average maintenance serum propofol levels (2.04 g/mL) consistent with those previously described as adequate for surgery (2-5 g/mL), and average decrement levels (0.35 g/ mL) 20 minutes after switching to an isoflurane combination far less than those needed for emergence (1.5 g/mL) (26, 27) . The propofol blood concentration required to suppress learning by 50% is 0.6 Ϯ 0.1 g/mL (28, 29) . Administering propofol only after the inhaled anesthetic combinations were studied would have eliminated this element of "propofol contamination;" however, we believed that randomization of the anesthetic sequences was essential for the study's validity.
Our results demonstrate that a propofol-based TIVA technique better preserves cortical SSEP amplitude measurement than combinations of small-dose isoflurane/N 2 O and small-dose isoflurane/air. On average, cortical amplitudes increased by 100% with the use of propofol compared to combinations of smalldose isoflurane/N 2 O. Isoflurane/air provided markedly better conditions than combinations of smalldose isoflurane/N 2 O, which confirms the negative additive effect of these drugs. Cortical latencies, subcortical amplitudes, and subcortical latencies did not differ among the four anesthetic groups as predicted by the adult literature. Our results suggest that propofol TIVA may be a better choice than small-dose isoflurane, with or without N 2 O, for patients with small baseline cortical amplitudes that require monitoring.
Another aim of our study was to compare the relative depth of hypnosis provided by each anesthetic combination. Intraoperative awareness is an important issue for patients and anesthesiologists (30) . Many patients who have experienced awareness go on to develop persistent posttraumatic stress disorder, and the ASA Closed Claims Database reveals that intraoperative awareness is a significant source of lawsuits against anesthesiologists (31) (32) (33) . Thus, efforts to optimize the general anesthetic environment for SSEP measurement must not be made at the expense of patient safety.
At this time, we do not have an ideal method or monitor for measuring depth of hypnosis. None of the patients in this study experienced intraoperative recall as determined by postoperative interview; however, the efficacy of intraoperative verbal/auditory challenges and postoperative interviews and psychological batteries to predict the risk of awareness may be limited. Nordstrom and Sandin (34) , for example, have documented 65% of patients subjected to "intentional awareness" during anesthesia experiencing complete amnesia for intraoperative events. In another study by Nordstrom et al. (24) , intraoperative recall was found in a patient only after extensive questioning on the eighth postoperative day. Kerssens et al. (35) have recently shown that only one fourth of patients who unequivocally responded to commands during anesthesia with isolated forearm technique were able to recall awareness on postoperative interview. Thus, we used the BIS monitor to objectively compare the depth of hypnosis among the different anesthetic combinations.
The BIS monitor is not a universally accepted monitor of awareness, either explicit or implicit, but it may provide a useful tool for predicting relative depths of hypnosis (35) . Values less than 60 are associated with profound hypnosis and a small reported incidence of intraoperative recall. Values more than 60, especially if maintained for long periods of time, may be associated with a significant risk of awareness according to some investigators (29, 30, (35) (36) (37) (38) . Our investigation revealed that propofol at 120 g · kg Ϫ1 · min Ϫ1 always translated into patient BIS values less than 60, whereas anesthetics consisting of isoflurane alone (0.6%) or combinations of isoflurane (0.4%-0.6%) and N 2 O 70% did not consistently produce BIS values less than 60.
Within this study, the addition of N 2 O 70% did not result in a difference in recorded BIS values. This finding is not unexpected given the results of previous investigations. Certain drugs, such as ketamine and N 2 O, alter electroencephalograph (EEG) variables in ways that make BIS measurement unpredictable. Barr et al. (39) have documented unconsciousness with N 2 O 70% but no change in BIS. Rampil et al. (40) also confirmed no change in BIS with N 2 O but documented patients that were fully cooperative and responsive at concentrations of 50%. Thus, in the context of measured BIS values, it may not be possible to estimate the full amnestic impact of adding N 2 O to a particular regimen. If the BIS monitor is to play any legitimate intraoperative role, we believe clinicians should only use anesthetics that have predictable, verifiable effects on BIS EEG variables.
In conclusion, our study demonstrates that, when added to baseline infusions of opioids and paralytics, a propofol-based hypnotic component can better preserve cortical SSEP amplitude measurement and provide a deeper level of hypnosis as measured by BIS than combinations of small-dose isoflurane/N 2 O 70% or small-dose isoflurane/air. Our results also dramatically confirm the negative effects of N 2 O on cortical SSEP amplitude measurement. Furthermore, although small-dose isoflurane/air provided excellent SSEP conditions, our measured BIS values indicate a potential risk for intraoperative recall. Using larger concentrations of isoflurane to increase amnestic potential may be a safer option, but this maneuver may be limited by the dose-dependent decrease in cortical amplitude previously described in the literature. Compared with N 2 O and isoflurane, propofol appears to be the superior hypnotic drug for cases requiring cortical SSEP measurement because it allows for robust amplitude measurement, and, in light of the work done by Boisseau et al. (16) demonstrating amplitude preservation in the setting of escalating propofol doses, one could potentially use much larger doses of drug to decrease the risk of intraoperative awareness.
